Projects per year
Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Leukemia
Medicine & Life Sciences
Small Cell Lung Carcinoma
Medicine & Life Sciences
Carboplatin
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Radiotherapy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 2004 2015
- 1 Finished
Participation In The Eastern Cooperative Oncology Group
National Institutes of Health (NIH)
9/2/04 → 2/28/15
Project: Research project
Chemoprevention
Research Personnel
Clinical Trials
Guideline Adherence
Synthetic Vaccines
Research Output 1974 2019
A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib
Castellano, G. M., Aisner, J., Burley, S., Vallat, B., Yu, H. A., Pine, S. & Ganesan, S., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.Research output: Contribution to journal › Article
Exons
Mutation
Lung Neoplasms
HM781-36B
Adenocarcinoma of lung
A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Sep 1 2019, In : Cancer chemotherapy and pharmacology. 84, 3, p. 567-578 12 p.Research output: Contribution to journal › Article
eribulin
Carboplatin
Non-Small Cell Lung Carcinoma
Labels
Tumors
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
Stein, M., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.Research output: Contribution to journal › Article
Carboplatin
Paclitaxel
Neoplasms
Area Under Curve
Prostate
Press/Media
New Evidence Against Heart Failure and Cancer Link
4/10/18
1 item of Media coverage
Press/Media: Press / Media
No Association Found Between HF and Cancer (CME/CE)
4/2/18
1 item of Media coverage
Press/Media: Press / Media